Merit Medical Systems Stock
Merit Medical Systems Stock
Merit Medical Systems gained 2.860% today.
The stock is an absolute favorite of our community with 26 Buy predictions and no Sell predictions.
With a target price of 89 € there is a positive potential of 23.61% for Merit Medical Systems compared to the current price of 72.0 €.
Pros and Cons of Merit Medical Systems in the next few years
Pros
?
C******** o* t** e**********
?
S********** s********
?
B****
Cons
?
M***** P*******
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Merit Medical Systems vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Merit Medical Systems | 2.860% | 9.375% | 15.702% | -2.098% | -5.405% | 7.692% | 28.440% |
| Haemonetics Corp. | 2.840% | 5.797% | 7.353% | - | 6.569% | - | - |
| Bio-Rad Labs Inc. A | -0.480% | 6.562% | 10.604% | 30.681% | 10.818% | -24.392% | -51.966% |
| CONMED Corp. | 0.500% | 2.732% | 25.333% | -12.558% | 7.429% | -64.860% | -67.863% |
Comments
Merit Medical Systems (MMSI) had its price target raised by JPMorgan Chase & Co. from $77.00 to $95.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for MMSI provided by MarketBeat
Merit Medical Systems (MMSI) had its "outperform" rating reaffirmed by Raymond James Financial, Inc..
Show more
Ratings data for MMSI provided by MarketBeat
Merit Medical Systems (MMSI) had its "overweight" rating reaffirmed by Piper Sandler.
Show more
Ratings data for MMSI provided by MarketBeat